PT - JOURNAL ARTICLE AU - Huang, Yunfeng AU - Bodnar, Dora AU - Chen, Chia-Yen AU - Gurria, Gabi AU - Sanderson, Mark AU - , AU - Shi, Jun AU - Meilleur, Katherine G AU - Hurles, Matthew E. AU - Gerety, Sebastian S. AU - Tsai, Ellen A. AU - Runz, Heiko TI - Rare genetic variants impact muscle strength AID - 10.1101/2022.06.22.22276715 DP - 2022 Jan 01 TA - medRxiv PG - 2022.06.22.22276715 4099 - http://medrxiv.org/content/early/2022/06/27/2022.06.22.22276715.short 4100 - http://medrxiv.org/content/early/2022/06/27/2022.06.22.22276715.full AB - Muscle strength is highly heritable and predictive for multiple adverse health outcomes including mortality. Here, we present a rare protein-coding variant association study in 340,319 individuals for hand grip strength, a proxy measure of muscle strength. We identify six significant genes (KDM5B, OBSCN, GIGYF1, TTN, RB1CC1, EIF3J), propose shared mechanisms between brain and muscle function and demonstrate additive effects between rare and common genetic variation on muscle strength.Competing Interest StatementY.H., D.B., C.C., J.S., K.G.M., E.A.T. and H.R. are employees of Biogen. M.E.H. is a co-founder, shareholder, non-executive director of Congenica, and an advisor to Astra-Zeneca.Funding StatementWe did not receive any external funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Collection of the UK Biobank (UKBB) data was approved by the UKBB's Research Ethics Committee. UKBB individual-level, phenotypic data and whole exome sequencing data used in the present work were obtained under application ID 26041.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSummary-level association results produced in the present study are contained in the Supplementary Materials. Additional data produced in the present study are available upon reasonable request to the authors.